Mural Oncology Plc (MURA)
NASDAQ:MURA
US Market
Holding MURA?
Track your performance easily

Mural Oncology Plc (MURA) Financial Statements

19 Followers

Mural Oncology Plc Financial Overview

Mural Oncology Plc's market cap is currently ―. The company's EPS TTM is $-10.345; its P/E ratio is -0.33; Mural Oncology Plc is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-1.97. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24
Income Statement-
Total Revenue-
Gross Profit-
EBIT$ -31.56M
EBITDA$ -30.66M
Net Income Common Stockholders$ -31.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 204.70M
Total Assets$ 234.93M
Total Debt$ 11.08M
Net Debt$ -193.62M
Total Liabilities$ 30.36M
Stockholders Equity$ 204.57M
Cash Flow-
Free Cash Flow$ -29.36M
Operating Cash Flow$ -29.36M
Investing Cash Flow$ 43.68M
Financing Cash Flow-
Currency in USD

Mural Oncology Plc Earnings and Revenue History

Mural Oncology Plc Debt to Assets

Mural Oncology Plc Cash Flow

Mural Oncology Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis